Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis

OBJECTIVE: To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations with clinical outcome measures. METHODS: The project was designed as a multicent...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilmore, Wendy, Lund, Brett T., Li, Peili, Levy, Alex M., Kelland, Eve E., Akbari, Omid, Groshen, Susan, Cen, Steven Yong, Pelletier, Daniel, Weiner, Leslie P., Javed, Adil, Dunn, Jeffrey E., Traboulsee, Anthony L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296935/
https://www.ncbi.nlm.nih.gov/pubmed/32539719
http://dx.doi.org/10.1186/s12974-020-01847-9

Ejemplares similares

Ejemplares similares